<i>Plasmodium falciparum</i> merozoite surface protein 1 as asexual blood stage malaria vaccine candidate-Reference-Cited by-同舟云学术

Plasmodium falciparum merozoite surface protein 1 as asexual blood stage malaria vaccine candidate

Author:

Thomson-Luque Richard¹²^ORCID,Stabler Thomas C³⁴⁵,Fürle Kristin¹,Silva Joana C⁶³⁷,Daubenberger Claudia⁴⁵

Affiliation:

1. Centre for Infectious Diseases-Parasitology, Heidelberg University Hospital, Heidelberg, Germany

2. Sumaya-Biotech GmbH & Co. KG Heidelberg, Germany

3. Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA

4. University of Basel Basel, Switzerland

5. Swiss Tropical and Public Health Institute Allschwil, Switzerland

6. Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA

7. Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade NOVA de Lisboa (GHTM IHMT, UNL), Lisbon, Portugal

Funder

U.S. National Institutes of Health

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

Reference159 articles.

1. Malaria vaccine: WHO position paper - January 2016;World Health Organization;Weekly Epidemiol Rec,2016

4. Cervellati M, Esposito E, Sunde U, et al. Malaria risk and civil violence. Munich, Germany: CESifo; 2017.